By Umang Saraf
If you walk into a sports court or run any marathon in India today, there’s a good chance you will find a Fast&Up product somewhere.
Fast&Up looks like a marketing story until you dig deeper. Behind the tube sits a pharma-grade facility, hundreds of prototypes tested every year, and a decade of disciplined building. The brand is the visible tip of a much deeper manufacturing and R&D engine.
We invested INR 300 crore in Fullife Healthcare (the parent company behind Fast&Up and Chicnutrix) in March 2026.
The Wave
Fullife sits inside one of India’s largest and fastest growing consumer categories, riding tailwinds that don’t depend on winning share from anyone.
- The market is large and compounding fast. Fullife’s relevant consumer health, wellness, and preventive nutrition market in India is worth $13.5 billion today and is expected to grow at a 16% CAGR to $28.1 billion by FY31.
- India is shifting from reactive to preventive health. Preventive health-checks in India rose 150% in five years (2019-2024) – a clear behavioural signal that consumers are managing health earlier rather than treating illness later.
- Fitness participation is compounding the demand curve. India’s gym-going population is expected to grow ~17% CAGR between FY24 and FY29, directly expanding demand for hydration, protein, and recovery products.
- The nutrient gap is structural, not cyclical. The average Indian consumes only ~60% of recommended protein intake, even as ultra processed food consumption and lifestyle stress continue to rise.
- The format itself is winning. Effervescent is the fastest-growing delivery format globally, ~12% of nutritional supplements today, rising to 17% by FY32, and it’s the format Fullife owns.
None of this requires Fullife to dislodge an entrenched incumbent. Fullife is already the number #1 effervescent hydration brand in India and the UAE. The pie is growing, and Fullife is positioned to capture a disproportionate share of that growth.
The Build
What drew us in wasn’t just the market but also how deliberately Fullife has been built over more than a decade.
A diversified revenue engine, not a single-product bet. Revenue is balanced across Hydration & Energy, Ingestible Beauty, Modern Lifestyle, and Active Nutrition.
A global footprint that’s real revenue, not aspiration. A significant portion of revenue already comes from international markets, with leadership established in the hydration category in major markets.
A manufacturing moat that’s hard to copy. Fullife runs end-to-end, in-house, EU-audited manufacturing for effervescent and modern nutrition formats out of a single pharma grade facility.
An NPD engine that actually converts. Fullife tests a few hundred product prototypes annually, with in-house stability, dissolution, bioavailability, sensory, and pilot manufacturing capability enabling 4-6 week product development cycles, against 3-4 months for brands that outsource manufacturing.
The Moat
Fullife’s durability rests on strengths that are genuinely difficult for a competitor to replicate.
Vertical integration end-to-end. Fullife owns product development and production, which means faster innovation cycles and tighter quality control than an asset-light challenger can match.
External validation few consumer brands ever face. The same facility that manufactures Fast&Up also produces for global pharma majors who audit it themselves, a level of scrutiny that’s simply unavailable to a brand sourcing from a generic contract manufacturer.
Category leadership that compounds. Fast&Up’s flagship SKUs, like Reload, hold the top market share position in India’s hydration category. That leadership creates shelf advantage, pricing power, and a platform to launch adjacent products into an audience that already trusts the brand.
Why We Invested
The rationale is straightforward:
- A market that is structurally growing.
- A profitable, diversified business today
- Real, defensible moats in-house pharma-grade manufacturing
- A global business built from India
- A founding team that has lived this problem for a decade
Fullife is a bet that India’s shift toward preventive, daily wellness is structural and that the company controlling both the science and the supply chain behind that shift, not just the brand on the shelf, is where a disproportionate share of the value gets built.